Compound Report Overview
Compound Identifier:
704130
Development Status:
Clinical Phase IIIII
SMILES:
CCNC(O)C1CCCN1C(O)C(CCCNC(N)N)NC(O)C(CC(C)C)NC(O)C(Cc2c(C)nHc3ccccc23)NC(O)C(Cc4ccc(O)cc4)NC(O)C(CO)NC(O)C(Cc5cnHc6ccccc56)NC(O)C(Cc7cncnH7)NC(O)C8CCC(O)N8